Syndecan-4 is a Novel Therapeutic Target for Intervertebral Disc Degeneration via Suppressing JNK/p53 Pathway
- Resource Type
- Journal
- Source
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES ; 2020, 16 5, p766-p776, 11p.- Subject
- Language
- English
- ISSN
- 14492288